week two semaglutide Day 2: Wegovy (Semaglutide 2.4 mg weekly injection) Class: GLP-1 receptor agonist Avg Weight Loss: ~15% of baseline weight Dosing: Weekly subcutaneous injection FDA Approved: June 2021 for chronic weight management Pros Semaglutide Dosing - Doctor's Advice

E66.3 for overweight) An ICD-10 code for the qualifying tier condition, where applicable The prescribing clinician's National Provider Identifier (NPI) and a statement that they are not on the CMS Preclusion List Documentation that the medication will be used alongside structured nutrition and physical activity Date of last clinical visit with the prescribing provider The specific medication being requested (Wegovy, Zepbound, or Foundayo) with dose and quantity Some Part D plans add requirements such as documented prior lifestyle intervention attempts, weight history over the past 24 months, or signed patient acknowledgment of the long-term nature of treatment

However, when misfolded and damaged proteins exceed the repair capacity of HSPs and ROS surpass the testicular antioxidant capacity, germ cells may exhibit irreversible injury and apoptosis, thereby contributing to male infertility

For subcutaneous injections, typical protocols start at 1mg daily and may increase to 2mg

L.BissonJ.GrahamJ.PauliG